Tumour associated immunity and immunocompetence in ovarian cancer.
Cell-free extracts of autologous ovarian cancer cells evoked a delayed hypersensitivity response (DHR) in skin in four out of six patients in remission from disease and none of seven patients in relapse. These initial results appear to be consistent with in vitro blastogenic assay using the same autologous extracts. To assess whether diminished tumour-associated immunity was due to impaired cell-mediated immunocompetence, blastogenic responses to purified protein derivative of tuberculin (PPD), a secondary recall antigen, and phytohaemagglutinin (PHA) were assessed. Impaired responses to PHA were seen in the relapse group of patients, but responses to PPD did not appear to be impaired in this group.
D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000473:pathology; D007109:Immunity; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D010051:Ovarian Neoplasms / Q000276:immunology*; D012075:Remission, Spontaneous; D012882:Skin Tests; D014373:Tuberculin
D037102:Lectins; D014373:Tuberculin